'An Exchange of Best Practice:
How to Mobilise Real World Datasets to
Accelerate Life Sciences R&D'
11 November, 09:00 - 11:00
OBN Digital Event:
'An Exchange of Best Practice: How to Mobilise Real World Datasets to Accelerate Life Sciences R&D'
In collaboration with the Swiss Business Hub UK+I at the Embassy of Switzerland in the UK
This special showcase event will feature companies from both Switzerland and the UK, who together will share insight into their work in medical data informatics, and show how real world data solutions are being used to improve efficiency in patient search and identification, and the potential positive impact this may have in the treatment of a range of diseases for the wider patient population.
09.00: Welcome by John Harris, CEO, OBN
09.05: Welcome by Alexandre Fasel, Ambassador of Switzerland to the UK
Company showcase presentations:
Mr Douglas Drake, Senior Director, Client Solutions at Clinerion - the worldwide leader in medical data informatics, radically improving efficiency in patient search and identification, increasing effectiveness in clinical research and accelerating the process of drug development to ensure an earlier availability of medicines (Basel, Switzerland)
Renee Deehan, Vice President, Computational Biology Quartzbio (Geneva Switzerland) Generating value from large-scale heterogeneous biomedical data - managing, analyzing, exploring, interpreting, and reporting - to create informed, sound, and actionable insights
Kevin Teburi Managing Director, Genedata (Basel, Switzerland) providing bioinformatics enterprise software solutions and a variety of software-related services that support large-scale, experimental processes in life science research- with a focus on automating data rich, highly complex data workflows (Basel, Switzerland)
Jane Theaker, CEO, Kinomica (UK) a proteomic-data science and diagnostics company specialising in cell signalling (Alderley Park, UK)
James Schofield, Director at TopMD Precision Medicine (UK) - using topology, the mathematical measurement of shape, to revoluntionise drug development and disease diagnosis by redefining biomarkers (Southampton, UK)
10.05 - 10.20: Live Q&A
10.20 - 11.00: Live networking via the Remo platform
About the event:
This session will be run in a live format, with registration open for both OBN Members and Non-Members.
A live Q&A will follow the keynote presentations and audience members will be encouraged to engage with hosts regarding their thoughts on the topic, and any personal experiences.
There will also be an opportunity to network with registered delegates after the Q&A with OBN's virtual networking platform - Remo. Details will be sent upon registration.
Tickets to this event are Complimentary
Organised in collaboration with the Swiss Business Hub UK+I at the Embassy of Switzerland in the UK